MiNK Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INKT and other ETFs, options, and stocks.About INKT
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
INKT Key Statistics
Stock Snapshot
The current MiNK Therapeutics(INKT) stock price is $11.26, with a market capitalization of 54.67M. The stock trades at a price-to-earnings (P/E) ratio of -3.77.
On 2026-05-08, MiNK Therapeutics(INKT) shares started trading at $11.00, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 22.33K.
Over the past 52 weeks, MiNK Therapeutics(INKT) stock has traded between a high of $76.00 and a low of $6.34.
Over the past 52 weeks, MiNK Therapeutics(INKT) stock has traded between a high of $76.00 and a low of $6.34.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.